Search

Home > OncLive® On Air > 42: FDA Approval Insights: Fixed-Dose Pertuzumab/Trastuzumab in HER2+ Breast Cancer
Podcast: OncLive® On Air
Episode:

42: FDA Approval Insights: Fixed-Dose Pertuzumab/Trastuzumab in HER2+ Breast Cancer
Category: Science & Medicine
Duration: 00:20:52
Publish Date: 2020-09-28 20:41:11
Description: In our exclusive interview, Antoinette R. Tan, MD, of Atrium Health, discusses the FDA approval of the fixed-dose combination of pertuzumab and trastuzumab in HER2-positive breast cancer and highlights the results of the pivotal FeDeriCa trial.
Total Play: 0

Some more Podcasts by Audioboom

70+ Episodes
Faith Moveme ..    
100+ Episodes
Videnskab.dk .. 5     1
20+ Episodes
Vidensselska ..    
10+ Episodes
Odd Jobs    
20+ Episodes
Aaron and Ga ..    
100+ Episodes
Ladies of Li .. 4     3
100+ Episodes
Chamber Podc ..    
10+ Episodes
IT'S A GROWN ..